Titin

Pet Supplements (and science) with Soul

Retrieved on: 
Thursday, September 9, 2021

BOULDER, Colo., Sept. 9, 2021 /PRNewswire/ --InClover ("InClover Research") leading, natural pet supplement company is raising the bar for sustainable pet supplements, and their mission to B Corporation Certification is just around the corner.

Key Points: 
  • BOULDER, Colo., Sept. 9, 2021 /PRNewswire/ --InClover ("InClover Research") leading, natural pet supplement company is raising the bar for sustainable pet supplements, and their mission to B Corporation Certification is just around the corner.
  • InClover offices share a backyard with the widely known non-profit, Pet Sustainability Coalition, dedicated to creating a positive impact within the pet industry for the communities and environments where we all do business.
  • This partnership and InClover's accreditation through PSC has led InClover to be, 'Best In Category' recipient for pet supplements for 2019 - 2020, and has guided InClover to exceed Sustainable Development Goals .
  • InClover pet supplements are certified by the NASC (National Animal Supplement Council).

TTN Fleet Solutions Weathers Texas Cold Spell

Retrieved on: 
Thursday, February 25, 2021
Software, Networks, Professional services, Data management, Public transport, Technology, Other Transport, Trucking, Other Professional Services, Transport, Other Technology, Logistics, Supply chain management, Consulting, Land transport, Road transport, Roadside assistance, Vehicle insurance, Transport, ttn, ttn, Titin

Todd Neiberger, Chief Executive Officer of TTN Fleet Solutions, issued a statement today regarding his companys service during recent, extreme Texas weather.

Key Points: 
  • Todd Neiberger, Chief Executive Officer of TTN Fleet Solutions, issued a statement today regarding his companys service during recent, extreme Texas weather.
  • The statement commended employees for keeping the emergency roadside assistance provider open during the cold spell.
  • Even as staff members were attending to personal, weather related emergencies, executives at TTN Fleet Solutions manned phone lines to ensure the companys roadside service commitments were met.
  • TTN Fleet Solutions helps customers achieve better business results with industry-leading vehicle maintenance and repair technology and services.

MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy

Retrieved on: 
Wednesday, September 9, 2020
RTT, Dilated cardiomyopathy, Cardiomyopathy, Branches of biology, MYH7, Titin, Medical specialties, Anatomy

Danicamtiv is MyoKardias most advanced clinical candidate being developed for the treatment of genetic dilated cardiomyopathy (DCM) and other targeted populations with conditions of reduced systolic function.

Key Points: 
  • Danicamtiv is MyoKardias most advanced clinical candidate being developed for the treatment of genetic dilated cardiomyopathy (DCM) and other targeted populations with conditions of reduced systolic function.
  • MyoKardias Phase 2 study of danicamtiv will enroll patients with DCM with documented genetic variants of MYH7 or titin.
  • MyoKardia intends to advance danicamtiv in further clinical studies to characterize clinical benefit, starting with a Phase 2 clinical trial in patients with genetic dilated cardiomyopathy.
  • Voors, et al, European Journal of Heart Failure, 2020
    Sinagra, et al, (editors), Dilated Cardiomyopathy: From Genetics to Clinical Management, Springer 2019
    Lund et al.